Hong Kong Exchanges and Clearing (HKEX) plans to launch the Hang Seng Biotech Index Futures next month, as offshore investors show heightened interest in mainland Chinese biopharmaceutical stocks listed in the city. The new futures contracts platform, which is expected to commence trading on November 28, aims to offer investors a risk management tool for “one of the fastest-growing and most dynamic sectors”, the exchange operator said on Tuesday. Built on the Hang Seng Biotech Index, the...